Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter
Alessia Grozio(Washington University in St. Louis), Shin‐ichiro Imai(Washington University in St. Louis), Santina Bruzzone(Ospedale Policlinico San Martino), Giovanna Sociali(University of Genoa), Kyohei Tokizane(Washington University in St. Louis), Jun Yoshino(Washington University in St. Louis), Yo Sasaki(SHOWA Medical University), Kathryn F. Mills(Washington University in St. Louis), Marie E. Migaud(USA Mitchell Cancer Institute), Hanyue Cecilia Lei(Washington University in St. Louis)
Cited by 16
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899